Bacterial pathogens are commonly identified in viral respiratory infections such as influenza and are an important cause of morbidity and mortality. The prevalence of bacterial infection in patients infected with SARS-CoV-2 is not well understood. This review aims to To determine the prevalence of bacterial co-infection (at presentation) and secondary infection (after presentation) in patients with COVID-19.